Ozurdex Versus Ranibizumab Versus Combination for Central Retinal Vein Occlusion

NCT01827722 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

45

Enrollment

OTHER

Sponsor class

Conditions

Macular Edema
Central Retinal Vein Occlusion

Interventions

DRUG: Ozurdex
DRUG: Ranibizumab
DRUG: Combination Ozurdex with Ranibizumab PRN

Sponsor

Valley Retina Institute